Cargando…
Radiotherapy-Related Gene Signature in Prostate Cancer
SIMPLE SUMMARY: Radiation therapy (RT) is an established therapeutic regimen for prostate cancer patients which aims for the direct elimination of tumor cells in the prostate gland and occasionally at distant anatomic sites. In this study, we performed next-generation sequencing-based gene expressio...
Autores principales: | Fortis, Sotirios P., Goulielmaki, Maria, Aubert, Nicolas, Batsaki, Panagiota, Ouzounis, Sotirios, Cavouras, Dionisis, Marodon, Gilles, Stokidis, Savvas, Gritzapis, Angelos D., Baxevanis, Constantin N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599894/ https://www.ncbi.nlm.nih.gov/pubmed/36291815 http://dx.doi.org/10.3390/cancers14205032 |
Ejemplares similares
-
Correction: Kogionou et al. Radiotherapy-Related Gene Signature in Prostate Cancer. Cancers 2022, 14, 5032
por: Kogionou, Paraskevi, et al.
Publicado: (2023) -
A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer
por: Fortis, Sotirios P., et al.
Publicado: (2023) -
Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
por: Goulielmaki, Maria, et al.
Publicado: (2023) -
The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer
por: Goulielmaki, Maria, et al.
Publicado: (2022) -
T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker
por: Baxevanis, Constantin N., et al.
Publicado: (2022)